Faeth Therapeutics, Inc. (FTH)
NASDAQ: FTH · Real-Time Price · USD
24.49
+1.57 (6.85%)
Jul 6, 2026, 4:00 PM EDT - Market closed
Faeth Therapeutics Market Cap
Faeth Therapeutics has a market cap or net worth of $631.32 million as of July 7, 2026. Its market cap has increased by 7,547.16% in one year.
Market Cap
631.32M
Enterprise Value
429.57M
1-Year Change
7,547.16%
Ranking
Category
Stock Price
$24.49
Market Cap Chart
Since February 4, 2021, Faeth Therapeutics's market cap has increased from $558.65M to $631.32M, an increase of 13.01%. That is a compound annual growth rate of 2.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 6, 2026 | 631.32M | 4,591.06% |
| Dec 31, 2025 | 13.46M | 9.18% |
| Dec 31, 2024 | 12.33M | -28.74% |
| Dec 29, 2023 | 17.30M | -62.21% |
| Dec 30, 2022 | 45.77M | -74.21% |
| Dec 31, 2021 | 177.46M | -68.23% |
| Feb 4, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SpyGlass Pharma | 640.25M |
| AgomAb Therapeutics NV | 622.99M |
| Nuvectis Pharma | 616.95M |
| Altimmune | 614.54M |
| ProKidney | 613.18M |
| MiMedx Group | 588.34M |
| Crescent Biopharma | 567.88M |
| Contineum Therapeutics | 564.53M |